GB1073309A - 18-nor-steroids - Google Patents
18-nor-steroidsInfo
- Publication number
- GB1073309A GB1073309A GB1426565A GB1426565A GB1073309A GB 1073309 A GB1073309 A GB 1073309A GB 1426565 A GB1426565 A GB 1426565A GB 1426565 A GB1426565 A GB 1426565A GB 1073309 A GB1073309 A GB 1073309A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrogen atom
- group
- hydroxy
- formyloxy
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises compounds of formula <F\1> wherein X is a C1- 6 alkenyl, or alkynyl group, Y is a hydrogen atom or a hydroxy or formyloxy group, Y1 is a hydrogen atom or a hydroxy, formyloxy or keto group and Z when present is a hydrogen atom or a methyl group, wherein rings A and B may contain one or more double bonds and/or additional substituents, and their preparation by heating a compound of formula <F\2> wherein Y1 is a hydrogen atom or a hydroxy group and Y11 is a hydrogen atom or a hydroxy or keto group, with formic acid, followed, if desired, by hydrolysis of any formyloxy groups. The compounds of the invention may be used in fertility control, treatment of carcinomas of the prostate or treatment of virilizing tumours of the suprarenals, as pharmaceutical composi sions in combination with a carrier, for example in forms suitable for oral, parenteral or rectal administration, including implants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1426565A GB1073309A (en) | 1965-04-05 | 1965-04-05 | 18-nor-steroids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1426565A GB1073309A (en) | 1965-04-05 | 1965-04-05 | 18-nor-steroids |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1073309A true GB1073309A (en) | 1967-06-21 |
Family
ID=10038029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1426565A Expired GB1073309A (en) | 1965-04-05 | 1965-04-05 | 18-nor-steroids |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1073309A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2068404A1 (en) * | 1969-10-13 | 1971-08-27 | Labo Prodotti Braglia | |
WO1986006078A1 (en) * | 1985-04-17 | 1986-10-23 | Schering Aktiengesellschaft | Skin treatment agents |
-
1965
- 1965-04-05 GB GB1426565A patent/GB1073309A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2068404A1 (en) * | 1969-10-13 | 1971-08-27 | Labo Prodotti Braglia | |
WO1986006078A1 (en) * | 1985-04-17 | 1986-10-23 | Schering Aktiengesellschaft | Skin treatment agents |
US4859659A (en) * | 1985-04-17 | 1989-08-22 | Schering Aktiengesellschaft | Dermatics utilizing 17βmethyl-18 nor steroids and methods for their use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1073309A (en) | 18-nor-steroids | |
ES407582A1 (en) | Halogenated 4-(4'-bisphenylyl)-butanols | |
GB1035683A (en) | New estrane derivatives, compositions incorporating them and processes for their preparation | |
ES285600A1 (en) | Procedure for the preparation of hardened resins (Machine-translation by Google Translate, not legally binding) | |
ES392784A1 (en) | 3beta-hydroxy-5alpha-cardenolides and-bufadienolides and process for their manufacture | |
GB1123104A (en) | 3-oxime-steroids and method of preparation | |
ES416433A1 (en) | Benzomorphan derivatives | |
GB933154A (en) | Improvements in or relating to steroidal lactones | |
ES308038A1 (en) | A procedure for the production of 5-phenyl-1,4-3h-benzodiazepin-2 (1H) -onas. (Machine-translation by Google Translate, not legally binding) | |
GB1066886A (en) | Imidazole derivatives | |
GB1074468A (en) | Carbalkoxyhtdrazones of the androstane adn estrane series | |
GB1065189A (en) | 6,6-ethylene pregnenes | |
GB1068500A (en) | Improvements in or relating to b-norestrogens | |
GB1120814A (en) | 10-iso steroids | |
ES392355A1 (en) | D-homosteroid imides and a process for the preparation thereof | |
ES361606A1 (en) | Procedure for the preparation of new 5-nitrofurilic derivatives. (Machine-translation by Google Translate, not legally binding) | |
GB1123305A (en) | A process for the manufacture of benzindenes | |
ES335414A1 (en) | Procedure for preparing quinoline compounds. (Machine-translation by Google Translate, not legally binding) | |
GB985482A (en) | 2-methylene testosterone derivatives and methods for producing the same | |
GB1088113A (en) | Cyclohexanol derivatives | |
GB900021A (en) | Steroid compounds and their preparation | |
GB1087648A (en) | Novel steroid compounds, and processes for their preparation | |
GB1115635A (en) | 13-alkylgonenes related to 19-norprogesterone | |
GR23323B (en) | METHODS FOR THE MANUFACTURE OF Steroid compounds. | |
GB961101A (en) | Steroid compounds |